Familial neurodegeneration in progressive supranuclear palsy: More frequent than expected?

Neurology

Volumn 73, Issue 2, 2009, Pages 86-87

  Pastor, Pau ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

TAU PROTEIN; MAPT PROTEIN, HUMAN;

AUTOSOMAL DOMINANT INHERITANCE; CHROMOSOME 17Q; CLINICAL FEATURE; DEGENERATIVE DISEASE; DEMENTIA; EDITORIAL; FAMILIAL DISEASE; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; HUMAN; NERVE DEGENERATION; NEUROLOGIC EXAMINATION; PARKINSONISM; PHENOTYPE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; FAMILY; GENETIC PREDISPOSITION; GENETICS; MUTATION; NOTE;

DEMENTIA; FAMILY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; PARKINSONIAN DISORDERS; SUPRANUCLEAR PALSY, PROGRESSIVE; TAU PROTEINS;

EID: 68149108184     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181aa2a71     Document Type: Editorial

References (11)

1. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy: a heterogeneous degeneration involving the brainstem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy: nuchal dystonia and dementia. Arch Neurol 1964;10:333-359.
2. Donker Kaat L, Boon AJW, Azmani A, et al. Familial aggregation of parkinsonism in progressive supranuclear palsy. Neurology 2009;73:98-105.
3. Williams DR, de Silva R, Paviour DC, et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 2005;128:1247-1258.
4. Donker Kaat L, Boon AJW, Kamphorst W, Ravid R, Duivenvoorden HJ, van Swieten JC. Frontal presentation in progressive supranuclear palsy. Neurology 2007;69:723-729.
5. Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA 1998;95:7737-7741.
6. Pastor P, Pastor E, Carnero C, et al. Familial atypical progressive supranuclear palsy associated with homozygosity for the delN296 mutation in the tau gene. Ann Neurol 2001;49:263-267.
7. Ferrer I, Pastor P, Rey MJ, et al. Tau phosphorylation and kinase activation in familial tauopathy linked to deln296 mutation. Neuropathol Appl Neurobiol 2003;29:23-34.
8. Conrad C, Andreadis A, Trojanowski JQ, et al. Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol 1997;41:277-281.
9. Rademakers R, Melquist S, Cruts M, et al. High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy. Hum Mol Genet 2005;14:3281-3292.
10. Cruchaga C, Vidal-Taboada JM, Ezquerra M, et al. 5′-Upstream variants of CRHR1 and MAPT genes associated with age at onset in progressive supranuclear palsy and cortical basal degeneration. Neurobiol Dis 2009;33:164-170.
11. Ros R, Gomez Garre P, Hirano M, et al. Genetic linkage of autosomal dominant progressive supranuclear palsy to 1q31.1. Ann Neurol 2005;57:634-641.